IBA is a Belgian scientific and medical technology company headquartered in Louvain-la-Neuve. It designs, produces, installs, maintains and upgrades particle accelerators and dosimetry equipment used by hospitals worldwide for cancer diagnosis and treatment. The company employs more than 2,300 people and operates internationally.
Its technical work spans several distinct domains: particle accelerator technology and proton therapy; dosimetry and radiation measurement; cyclotrons and radiochemistry; electron-beam and X-ray systems; and radiopharmaceutical solutions. The product portfolio reflects this range. Proton Therapy systems are used for cancer treatment in hospitals. Dosimetry equipment provides radiation measurement instruments for cancer diagnosis and treatment. RadioPharma Solutions supplies cyclotrons and radiochemistry for radiopharmaceutical production. Industrial Solutions covers electron-beam and X-ray systems for sterilising medical devices and other industrial applications.
IBA works across healthcare and hospitals, oncology and cancer care, medical device sterilisation, industrial manufacturing and radiopharmaceuticals. Engineers, scientists and technologists collaborate directly with oncologists, healthcare organisations and industrial partners on customer projects. Long-term exploration is built into ways of working through the Discovery Lab, which investigates new applications and technologies.
The company describes its mission as protecting, enhancing and saving lives, takes a stakeholder approach to business, and is a certified B Corp, reflecting a commitment to responsible and sustainable practice.
